Skip to main content
PMC home page
Biotechnology Reports logoLink to Biotechnology Reports
. 2019 Jun 5;24:e00350. doi: 10.1016/j.btre.2019.e00350

Enhanced bone regeneration capability of chitosan sponge coated with TiO2 nanoparticles

Radyum Ikono a,b,c,⁎, Ni Li d, Nanda Hendra Pratama a, Agnia Vibriani e, Diah Retno Yuniarni f, Muhammad Luthfansyah a, Boy Muchlis Bachtiar g, Endang Winiati Bachtiar g, Kamarza Mulia h, Mohammad Nasikin h, Hideaki Kagami c,d,k, Xianqi Li d, Etik Mardliyati i, Nurul Taufiqu Rochman j, Tokiko Nagamura-Inoue l, Arinobu Tojo c
PMCID: PMC6606563  PMID: 31304101

Highlights

  • •

    Chitosan hybridized with titanium dioxide nanoparticles improves its bone regeneration capability.

  • •

    Nano titanium dioxide addition to the matrix of chitosan sponges was done successfully, as depicted from an even distribution of nano titanium dioxide on the surface of the sponges.

  • •

    Chitosan – nanoTiO2 scaffold results in significantly improved sponge robustness, biomineralization, and bone regeneration capability, as indicated by DMP1 and OCN gene upregulation in chitosan-50% nanoTiO2 sample.

Keywords: Bone regeneration, Chitosan, Sponges, TiO2 nanoparticles, Tissue engineering

Abstract

Chitosan has been a popular option for tissue engineering, however exhibits limited function for bone regeneration due to its low mechanical robustness and non-osteogenic inductivity. Here we hybridized chitosan with TiO2 nanoparticles to improve its bone regeneration capability. Morphology and crystallographic analysis showed that TiO2 nanoparticles in anatase-type were distributed evenly on the surface of the chitosan sponges. Degradation test showed a significant effect of TiO2 nanoparticles addition in retaining its integrity. Biomineralization assay using simulated body fluid showed apatite formation in sponges surface as denoted by PO4− band observed in FTIR results. qPCR analysis supported chitosan - TiO2 sponges in bone regeneration capability as indicated by DMP1 and OCN gene upregulation in TiO2 treated group. Finally, cytotoxicity analysis supported the fact that TiO2 nanoparticles added sponges were proved to be biocompatible. Results suggest that chitosan-50% TiO2 nanoparticles sponges could be a potential novel scaffold for bone tissue engineering.

1. Introduction

Nano Titanium dioxide (TiO2) has been widely investigated for many applications, due to its unique properties exhibited in nano size [[1], [2], [3], [4]]. Some prominent applications due to its photocatalytic activity, self-cleaning surface ability, low toxic and others [[5], [6], [7], [8], [9], [10]]. Despite extensive investigations of nano TiO2 on diverse fields, its discussion on its potentials in tissue engineering field are still limited.

Several studies have shown that nano TiO2 could improve bioactivity and mechanical properties [39,40], when coated in a composite-like structure with, for instance bioglass, silk, and other polymers [[11], [12], [13], [14], [15], [16], [17], [18]]. Nevertheless, study on nano TiO2 coating to other type of biopolymers, also its possibility to induce osteogenesis has yet to be elucidated thoroughly.

In this study, we used chitosan that has long been used in many biomedical applications as sponge, hybridized with TiO2 nanoparticles. Chitosan has been regarded as a biocompatible carbohydrate polymers that have been tested widely for biomaterials application, including tissue regeneration [[19], [20], [21]]. In terms of oral tissues, chitosan has been proven to be able to act as a supporting matrix for regeneration of several soft oral tissues [[22], [23], [24], [25], [26]]. However, chitosan alone as a scaffold for regeneration has a limited function for bone formation [27].

At present, most commonly used scaffolds for bone tissue engineering are hard type biomaterials including hydroxyapatite and β-tricalcium phosphate. Although relatively soft and flexible texture of chitosan is beneficial and may fit better for complex shape cavities, several studies have highlighted that chitosan scaffold could easily be degraded in the body due to insufficient mechanical properties [28,29]. The insufficiency in mechanical properties also leads to inadequate capacity for bone formation [30]. Mooney et al, for instance, reported that the mechanical properties of the scaffold is strongly correlated to the type of tissue targeted to be regenerated; thus for hard tissue (e.g. bone, dental) regeneration, scaffold with higher strength is more preferable [31]. We hypothesized that coating with nano TiO2 will significantly improve its bioactivity, mechanical properties, and also osteogenic inductivity, thus promote accelerated bone formation. If that is the case, chitosan-nano TiO2 system could be useful to regenerate bone in uncommon shape cavities, which are commonly observed for tooth extraction socket, periodontal tissue defect and the cavities after tumour or cyst removal.

Previous study by Kumar (2018) showed that chitosan scaffold doped by nano TiO2 resulting improvement on physiochemical properties. Nevertheless, its biological activity, especially on bone formation capability, as well as osteoinductivity was yet to be examined. This research main focus is to investigate chitosan-nano TiO2 biological activity, specifically on its bone formation and osteogenesis supporting capability.

2. Materials and methods

All procedures of experiments using animals in this study were performed in accordance with “The guidelines laid down by the National Institute of Health (NIH) in the USA” regarding the care and use of animals for experimental procedures and approved by “Matsumoto Dental University Committee on Intramural Animal Use” (No. 289).

2.1. Fabrication of chitosan-nano TiO2 hybrid sponge

The chitosan-nano TiO2 sponge (CTS) was prepared by dissolving 1 g of chitosan powder (Sigma Aldrich) and nano TiO2 with particle size 20 nm (Degussa p25, purity: 99.9%) (wt% of TiO2:chitosan was set at 1:2, 1:4, 1:8) into 50 ml of 1% (v/v) CH3COOH (Merck) in the glass beaker to yield solution A. The solution A was then stirred vigorously for 1 h to homogenize the solution. The solution of NaOH (Merck) was prepared by diluting 2 g of NaOH with 50 ml of deionized water in the glass beaker, yielding solution B. CTS was synthesized by adding solution A into solution B at room temperature, stirred until precipitate was formed, then separated from the solution using paper filter. The CTS was then placed into a 96-well culture plate (as a mold) and was frozen overnight at -300C. The frozen CTS was then lyophilized, then subsequently washed in the deionized water two times to obtain final CTS.

2.2. Surface morphology observation of the sponges

Scanning electron microscope (SEM) was used to study the surface morphology of the CTS. The analysis was carried out using a SEM (FEI Quanta 650) with an Oxford INCA/ENERGY-350 microanalysis system.

2.3. Crystallographic analysis of the sponges

To confirm the crystal structure of nano TiO2 after addition to chitosan solution, X-Ray diffraction analysis was carried out using XRD diffractometer (XRD, RIGAKU, RINT 2100/PC) with a CuKα (λ =1.5406 Å)

2.4. Biomineralization activity of the sponges

CTS with equal weight was immersed in 1x simulated body fluid (SBF) solution and incubated in closed tube at 370C for 1 and 2 weeks. After that, CTS was washed three times using deionized water to remove adsorbed mineral, and appearance after treatment was captured by digital camera. Chemical analysis of the samples were performed by FTIR spectroscopy. Experiment was conducted in triplicate.

2.5. Preparation of mouse mesenchymal stem cells (MSCs)

Male C57BL/6 J mice (3 weeks old, SLC Japan, Hamamatsu, Japan) were sacrificed with overdose anesthesia. The femurs and tibiae were disconnected from the trunk and soft tissues were removed from the bone surface thoroughly. Epiphyses were cut and bone marrow was flushed out using a syringe and #27 needle with a culture medium consisted with α-minimum essential medium with glutamine and phenol red (α-MEM, Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 1% penicillin-streptomycin-amphotericin B solution (Biological Industries Israel Beit Haemek Ltd., Kibbutz Beit Haemek, Israel). The mononuclear cells were separated in order to obtain pure cells homogenate, using density gradient centrifugation (Lymphoprep™, Cosmo Bio Co. Ltd., Tokyo, Japan) as indicated by the manufacturer’s protocol. The isolated mononuclear cells were washed twice and seeded on a culture dish (Falcon®, Corning, USA) at the density of 5.5 × 105/cm2 in the basic culture medium consisted with α-MEM supplemented with 10% FBS, 1% penicillin-streptomycin-amphotericin solution and 10 ng/ml recombinant human basic-fibroblast growth factor (b-FGF; Pepro Tech, Rocky Hill, NJ, USA). The primary cells were cultured at 37 ℃ in a 5% CO2 humidified incubator. Medium was changed every three days. When the cells reached 70–80% confluence, the cells were detached with 0.25% trypsin-EDTA (Gibco: Life Technologies, Carlsbad, CA, USA) and subcultured in a new culture dish at a density of 1.5 × 104 cells/cm2 until subconfluent. The cells at second passage were used in this study.

2.6. Osteogenic induction of MSCs on the sponges

All sponges were sterilized with UV irradiation for 30 min. When the MSCs reached 50–60% confluence, 1 × 104 cells/cm2 was cultured on the sponges of different nano TiO2 concentration (0%, 12.5%, 25%, and 50%). The basic culture medium was then replaced with osteogenic induction medium (basic culture medium supplemented with 100 nM dexamethasone (Sigma-Aldrich, St. Louis, MO, USA), 50 μM L-ascorbate acid phosphate (Wako Pure Chemical Industries, Ltd.) and 10 mM glycerol phosphate disodium salt hydrate (Sigma-Aldrich Co. LLC.). During the induction process, the media were changed every two days.

2.7. RNA extraction and quantitative real-time RT-PCR (qRT-PCR)

qRT-PCR was performed to determine the expression of osteogenic markers (OCN gene and DMP1 gene). Briefly, total RNA was extracted using TRIzol reagent (Ambion®; Life Technologies, Carlsbad, CA, USA). After quantification of total RNA with a spectrophotometer (Nano Drop® ND-1000, Thermo Fisher Scientific, Waltham, MA, USA), RNA samples were reverse-transcribed into complementary DNA (cDNA) using oligo (dT)12–18 primers (Life Technologies), dNTPs (Toyobo Co. Ltd, Osaka, Japan) and ReverTra Ace® (Toyobo Co., Ltd.) according to the manufacturer’s instructions. qRT-PCR were performed in a thermal cycler (Thermal Cycler Dice Real Time System II TP-900, Takara Bio, Japan) using SYBR Premix Ex TaqII reagent (Takara Bio, Kusatsu, Japan) according to the manufacturer’s protocol. Primer sets (Sigma-Aldrich Co.) used for the PCR experiment were listed in Table 1.

Table 1.

qRT-PCR primer sets.

Primer Direction Sequence (5’-3’)
β-Actin forward CATCCGTAAAGACCTCTATGCCAAC
reverse ATGGAGCCACCGATCCACA
DMP1 forward AGTGAGTCATCAGAAGAAAGTCAAGC
reverse CTATACTGGCCTCTGTCGTAGCC
Ocn forward CTCTGTCTCTGACCTCACAG
reverse GGAGCTGCTGTGACATCCATAC
Open in a new tab

2.8. Cytotoxicity analysis

For the cytotoxicity analysis, mouse bone marrow MSCs were prepared as described above. MSCs (2.5 × 105) were seeded on each scaffold (30 mg, approximately 0.8 × 0.8 x 0.8 mm) and the cell number was measured at day 5 after seeding. Less cell number correspond to higher cytotoxicity of the CTS. Cell number were evaluated with a WST-8 assay (Cell Counting Kit-8, Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer’s instructions. The value of Cell Counting Kit-8 was measured at 450 nm in a multi-detection microplate reader POWERSCAN® HT (Dainippon Pharmaceutical, Osaka, Japan).

2.9. Visualization of attached cells on the scaffold

Mouse bone marrow MSCs were seeded on the scaffold and cultured for 24 h. Then the cell-scaffold complexes were fixed with 4% formalin, washed in PBS, and incubated with 0.2% crystal violet (Wako) at room temperature for 5 min. After washing with distilled water, the scaffold with cells was put on a dish, cover slipped and observed under a stereoscopic microscope (LEICA MZ6, Leica Microsystems)

2.10. Statistical analysis

The results were presented as means ± standard error of means. Statistical analyses were conducted using Student’s t-test between two groups. The P-value of less than 0.05 was considered statistically significant.

3. Results

Chitosan – nano TiO2 sponges were successfully fabricated. Fig. 1 shows the morphology of the CTS at 100x magnitude using SEM.

Fig. 1.

Fig. 1

Open in a new tab

SEM images of chitosan (chi) - nano TiO2 (NT) sponge of different treatment group: (A) control, (B) chi-12.5%NT, (C) chi-25%NT, and (D) chi-50%NT (E) SEM – EDS image of chi-12.5%NT sponge.

All sponges showed significant number of pores and interconnectivity, as standard requirements of good scaffold in tissue engineering application. TiO2 nanoparticles were spread relatively evenly in all samples added with TiO2 nanoparticles. Qualitatively, increasing concentration led to more TiO2 nanoparticles attached to the surface of the chitosan sponges, as depicted in Fig. 1D that agglomeration of TiO2 was observed in some parts of the sponge. The TiO2 addition was also confirmed quantitatively by EDS analysis, as shown in Table 2, apparent concentration value of Ti and O element has the highest value compared to other elements.

Table 2.

Quantitative Results of EDS Analysis of chi-12.5% NT sponge.

Element Spectrum 1
 Spectrum 2
 Spectrum 3
Wt
(%)		 Atomic(%) Apparent Conc. Wt
(%)		 Atomic (%) Apparent Conc. Wt
(%)		 Atomic (%) Apparent Conc.
C 6.44 12.23 5.06 6.94 14.78 3.77 8.09 15.42 5.35
O 44.63 63.59 45.50 32.65 52.21 19.00 41.59 59.54 34.26
Na 1.75 1.73 2.89 1.26 1.41 1.45 1.91 1.90 2.67
Ti 47.19 22.46 61.79 59.15 31.60 55.15 48.41 23.14 53.30
Total: 100.0 100.0 100.0 100.0 100.0 100.0
Open in a new tab

XRD analysis was further carried out to confirm the existence, also the crystal structure of TiO2 after sponge synthesis. It can be inferred from Fig. 2 that TiO2 existed in the sponge with increasing pattern, as increasing TiO2 concentration. It was further confirmed that TiO2 maintained its anatase crystal structure.

Fig. 2.

Fig. 2

Open in a new tab

XRD analysis of different sample groups. This graph shows that addition of TiO2 to the sponge did not affect the crystal structure of TiO2 shown by anatase crystal structure retention. (NT—X : nano TiO2 – concentration used).

Fig. 3A showed the physical appearance of sponges after degradation behaviour test using SBF for 2 weeks. Hybridized sponges (in all treatment groups) showed physical integrity up to 2 weeks of incubation in SBF, while control group (chitosan only) was found to be collapsed only within 7 days, as shown in Fig. 3A.

Fig. 3.

Fig. 3

Open in a new tab

Physical appearance (A) and IR spectrum (B) of samples after incubation in SBF solution.

Biomineralization induction was confirmed in this study by FTIR spectroscopy in Fig. 3B. As expected, peaks for C Created by potrace 1.16, written by Peter Selinger 2001-2019 O amide I (±1600 cm−1), C–H amide II (±1300 cm−1), C—H amide III (±1000 cm−1), and NH2 amine (±3400 cm−1) that indicate chitosan were found in all samples. Besides, the FTIR of all chi-NT scaffold samples has shown characteristics bands for phosphate groups in ±600 cm−1. The carbonate group (±1400 cm−1) from bioapatite is overlapped with C—H amide II groups from chitosan, therefore cannot be seen as a clear band.

Moreover, to strengthen bioactivity potential from scaffold, osteogenic differentiation capability was carried out to investigate the effect of TiO2 nanoparticles presence towards bone formation. Fig. 4 shows that addition of 50% TiO2 nanoparticles significantly improved bone regeneration capability as shown in DMP1 and OCN gene upregulation more than two-fold compared to control sample (chitosan sponge only).

Fig. 4.

Fig. 4

Open in a new tab

DMP1 gene and OCN gene expressions of cells seeded on the scaffold. An asterisk (*) marks represent significant differences between group for DMP1 gene, and an octothorp (#) marks represent significant differences between group for OCN gene (p-value < 0.05).

Biocompatibility was also demonstrated from cell attachment on the sponge and cytotoxicity analysis using WST assay. Fig. 5 showed that higher concentration of nano TiO2 led to more cells attached on the scaffold.

Fig. 5.

Fig. 5

Open in a new tab

Cell attachment on the scaffold in 40x magnification after staining with crystal violet (Magnification: 1500x).

Cytotoxicity analysis was conducted after 5 days culture and it could be depicted from Fig. 6 that cell could proliferate well in all treatment groups, with a trend of increasing cell number as TiO2 concentration increased. These results is in line with the cells attachment image in Fig. 5.

Fig. 6.

Fig. 6

Open in a new tab

Cytotoxicity analysis using WST assay after 5 days cell culture. Hybridized TiO2 on the chitosan scaffold can significantly improve biocompatibility properties of the scaffold.

4. Discussion

In this work, we investigated the effect of TiO2 nanoparticles addition to chitosan sponge, with an idea to improve its mechanical properties and osteoinductive capability. Our results showed that chitosan – nano TiO2 sponges could be fabricated in accordance with widely accepted standard of scaffold for tissue regeneration. Scaffolds in tissue regeneration plays a significant role as a site where cells, growth factors and other cytokines to interact, finally to give a shape for tissue regeneration. Scaffolds for tissue regeneration purpose normally need to satisfy following physical characteristics: significant presence of pores, interconnected pores, uniform pore size and even distribution, also robustness (not easily collapsed) [[32], [33], [34]].

We further confirmed that nano TiO2 addition to the matrix of chitosan sponges was done successfully, as depicted from an even distribution of nano TiO2 on the surface of the sponges. Hybridization of sponges could face several challenges, such as pore collapse and uneven distribution. Pore collapse might happen when new materials addition covered the surface of pores, while uneven distribution could happen due to insufficient reagent or experimental error (insufficient stirring time/speed, incomplete dissolution leading to precipitation, etc.). Even distribution of TiO2 nanoparticles on the surface of sponges would ensure that mechanical and biological improvement of the sponges would also be taking place throughout the sponges area. Further existence of nano TiO2 on surface of sponges was confirmed by crystallographic analysis using XRD. The data showed that TiO2 maintained its crystal structure of anatase following its synthesis process with chitosan sponge. All the data could bring an insight that the hybridization process of chitosan and nano TiO2 by means of solvent casting (with aid of lyophilisation) could already deem a proven method. The method was actually a widely-used methods by other researchers to hybridize, for instance, chitosan with biocompatible polymers, such as PLGA, PCL, as well as ceramic materials, such as hyhdroxyapatite, SiO2, etc [[35], [36], [37], [38]].

Biological evaluation of sponges also showed promising results. One of the problems faced by chitosan sponges is their relatively fast degradation time. Accordingly, many argued that chitosan is not a suitable candidate for tissue regeneration, especially for hard tissues. In our work, we proved that chitosan with as little as 12.5 wt% addition could maintain its integrity after 2 weeks of culture in simulated body fluid (SBF), while chitosan only sponge already collapsed in day 7. In this study, SBF was also used to evaluate biomineralization from scaffold indicated by apatite formation. SBF has ion concentration equal to human blood plasma. From FTIR results, PO4− band (represents hydroxyapatite formation) was observed in all chitosan–nano TiO2 scaffold. Phosphate group is important functional groups indicate hydroxyapatite formation, which indicates its biomineralization induction capability. These results prove that adding TiO2 to chitosan scaffold can improve biomineralization activity. Apatite formation has been considered as an important factor for mineralization capability of implants, especially for bone implant [46]. In addition, previous studies [44,45] reported that material can bond to living bone through apatite layer which forms in its surface.

Furthermore, osteogenic induction analysis of the cells seeded on the scaffolds were conducted by examining DMP1 and OCN gene expressions. Dentin Matrix Protein 1 (DMP1) is a bone-specific important marker for osteocyte formation and phosphate metabolism for maintaining mineralization of the bone extracellular matrix. Mutation on DMP1 gene could cause abnormalities in bone development, such as osteomalcia and rickets [47,48]. Whereas, osteocalcin (OCN) plays its role when precursor cells committed to differentiate into mature osteoblasts. Osteocalcin is only secreted by osteoblasts and has endocrine function [49,50]. Both genes are prominent late markers in osteogenic differentiation. According to Fig. 4, sponge with 50% nano TiO2 showed the highest expression on DMP1 and OCN gene, indicating sponge ability to support MSCs cells differentiation into osteoblasts. MSCs differentiation into osteoblasts, or osteogenesis is a process that is strongly influenced by the matrix at which differentiation occurs. TiO2 improves matrix biomimeticity for bone formation supported by its high bioactivity and higher stiffness/overall mechanical properties that resembles bone in vivo [51]. Nevertheless, addition of nano TiO2 up to 25% showed to have reverse effect on the differentiation. Report has showed that nano TiO2 presence as a filler have no significant effect for osteogenesis at a considerably low amount [51]. Furthermore, reverse effect on the differentiation might be in effect due to UV irradiation process during sterilization, that causes chitosan to be degraded [52]. Since focal adhesion (FA) is known to be important for the differentiation of osteogenic cells, reduced adhesion due to the degradation of scaffold may suppresses FA formation, stress fiber polarization, cell stiffness and osteogenic commitments in MSCs [53]. Another important issue in this study was the biocompatibility of chitosan-nano TiO2 scaffold. The results from microscopic image in Fig. 5 and WST assay in Fig. 6, proved that cells could attach and proliferate well in chitosan – nano TiO2 composite sponges. This is in line with the results showing that nano TiO2 was considered as a biocompatible material, with no sign of toxicity during culture [[41], [42], [43]]. From these data, chitosan - 50% nano TiO2 sponges has demonstrated its prominent ability in biomineralization, osteogenic induction, and biocompatibility.

5. Conclusion

Hybridize chitosan with nano TiO2 to make a sponge, results in significantly improved sponge robustness, biomineralization and bone regeneration capability, as indicated by DMP1 and OCN gene upregulation in chitosan - 50% nano TiO2 group. Therefore, chitosan-50% nano TiO2 nanoparticles sponges could be a potential novel scaffold for bone tissue engineering, especially in the cases of complex cavity form.

Acknowledgements

This work was supported by Japan Society for the Promotion of Science (JSPS) (ID no: R11525) and in part by Grant-in-Aid for Scientific Research (B) (JSPS Kakenhi Grant Number JP16H05546).

References

  • 1.Weir A., Westerhoff P., Fabricius L., von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012;46:2242–2250. doi: 10.1021/es204168d.Titanium. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wen J., Li X., Liu W., Fang Y., Xie J., Xu Y. Photocatalysis fundamentals and surface modification of TiO2 nanomaterials. Chin. J. Catal. 2015;36:2049–2070. doi: 10.1016/S1872&#x02010;2067(15)60999-8. [DOI] [Google Scholar]
  • 3.Ahmad R., Mohsin M., Ahmad T., Sardar M. Alpha amylase assisted synthesis of TiO2 nanoparticles: structural characterization and application as antibacterial agents. J. Hazard. Mater. 2014;283:171–177. doi: 10.1016/j.jhazmat.2014.08.073. [DOI] [PubMed] [Google Scholar]
  • 4.Chen X., Liu L., Huang F. Black titanium dioxide (TiO2) nanomaterials. Chem. Soc. Rev. 2015;44:1861–1885. doi: 10.1039/c4cs00330f. [DOI] [PubMed] [Google Scholar]
  • 5.Kale B.M., Wiener J., Militky J., Rwawiire S., Mishra R., Jacob K.I., Wang Y. Coating of cellulose-TiO2 nanoparticles on cotton fabric for durable photocatalytic self-cleaning and stiffness. Carbohydr. Polym. 2016;150:107–113. doi: 10.1016/j.carbpol.2016.05.006. [DOI] [PubMed] [Google Scholar]
  • 6.Fagan R., McCormack D.E., Dionysiou D.D., Pillai S.C. A review of solar and visible light active TiO2 photocatalysis for treating bacteria, cyanotoxins and contaminants of emerging concern. Mater. Sci. Semicond. Process. 2016;42:2–14. doi: 10.1016/j.mssp.2015.07.052. [DOI] [Google Scholar]
  • 7.Wang H., Liu Y., Li M., Huang H., Xu H.M., Hong R.J., Shen H. Multifunctional TiO2 nanowires-modified nanoparticles bilayer film for 3D dye-sensitized solar cells. Optoelectron. Adv. Mater. Rapid Commun. 2010;4:1166–1169. doi: 10.1039/b000000x. [DOI] [Google Scholar]
  • 8.Lu X., Hu Y. Layer-by-layer deposition of TiO2 nanoparticles in the wood surface and its superhydrophobic performance. BioResources. 2016;11:4605–4620. doi: 10.15376/biores.11.2.4605-4620. [DOI] [Google Scholar]
  • 9.Wu Y., Zhou Z., Tuo Y., Wang K., Huang M., Huang Y., Shen S. A transparent CNTs/TiO2 composite film with superhydrophobic and photocatalytic functions self-assembled by liquid-phase deposition. Mater. Chem. Phys. 2015;149:522–529. doi: 10.1016/j.matchemphys.2014.11.002. [DOI] [Google Scholar]
  • 10.Wang T., Jiang H., Wan L., Zhao Q., Jiang T., Wang B., Wang S. Potential application of functional porous TiO2 nanoparticles in light-controlled drug release and targeted drug delivery. Acta Biomater. 2015;13:354–363. doi: 10.1016/j.actbio.2014.11.010. [DOI] [PubMed] [Google Scholar]
  • 11.Li X., Cui R., Liu W., Sun L., Yu B., Fan Y., Feng Q., Cui F., Watari F. The use of nanoscaled fibers or tubes to improve biocompatibility and bioactivity of biomedical materials. J. Nanomater. 2013;(2013):1–16. doi: 10.1155/2013/728130. Article ID 728130. [DOI] [Google Scholar]
  • 12.Durgalakshmi D., Rakkesh R.A., Balakumar S. Stacked Bioglass/TiO2 nanocoatings on titanium substrate for enhanced osseointegration and its electrochemical corrosion studies. Appl. Surf. Sci. 2015;349:561–569. doi: 10.1016/j.apsusc.2015.04.142. [DOI] [Google Scholar]
  • 13.Díez-Pascual A.M., Díez-Vicente A.L. Nano-TiO2 reinforced PEEK/PEI blends as biomaterials for load-bearing implant applications. ACS Appl. Mater. Interfaces. 2015;7:5561–5573. doi: 10.1021/acsami.5b00210. [DOI] [PubMed] [Google Scholar]
  • 14.Ferraris S., Bobbio A., Miola M., Spriano S. Micro- and nano-textured, hydrophilic and bioactive titanium dental implants. Surf. Coatings Technol. 2015;276:374–383. doi: 10.1016/j.surfcoat.2015.06.042. [DOI] [Google Scholar]
  • 15.Qi X., Pei P., Zhu M., Du X., Xin C., Zhao S., Li X., Zhu Y. Three dimensional printing of calcium sulfate and mesoporous bioactive glass scaffolds for improving bone regeneration in vitro and in vivo. Sci. Rep. 2017;7:2–13. doi: 10.1038/srep42556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wang H., Xian G., Li H. Grafting of nano-TiO2 onto flax fibers and the enhancement of the mechanical properties of the flax fiber and flax fiber/epoxy composite. Compos. Part A Appl. Sci. Manuf. 2015;76:172–180. doi: 10.1016/j.compositesa.2015.05.027. [DOI] [Google Scholar]
  • 17.Foruzanmehr Mr., Vuillaume P.Y., Robert M., Elkoun S. The effect of grafting a nano-TiO2thin film on physical and mechanical properties of cellulosic natural fibers. Mater. Des. 2015;85:671–678. doi: 10.1016/j.matdes.2015.06.105. [DOI] [Google Scholar]
  • 18.Pinto D., Bernardo L., Amaro A., Lopes S. Mechanical properties of epoxy nanocomposites using titanium dioxide as reinforcement - a review. Constr. Build. Mater. 2015;95:506–524. doi: 10.1016/j.conbuildmat.2015.07.124. [DOI] [Google Scholar]
  • 19.Jorfi M., Foster E.J. Recent advances in nanocellulose for biomedical applications. J. Appl. Polym. Sci. 2015;132:1–19. doi: 10.1002/app.41719. [DOI] [Google Scholar]
  • 20.Africa S. vol. 4. 2017. pp. 411–427. (HHS Public Access). [DOI] [Google Scholar]
  • 21.Lu Z., Gao J., He Q., Wu J., Liang D., Yang H., Chen R. Enhanced antibacterial and wound healing activities of microporous chitosan-Ag/ZnO composite dressing. Carbohydr. Polym. 2017;156:460–469. doi: 10.1016/j.carbpol.2016.09.051. [DOI] [PubMed] [Google Scholar]
  • 22.Rodríguez-Vázquez M., Vega-Ruiz B., Ramos-Zúñiga R., Saldaña-Koppel D.A., Quiñones-Olvera L.F. Chitosan and its potential use as a scaffold for tissue engineering in regenerative medicine. Biomed Res. Int. 2015;(2015) doi: 10.1155/2015/821279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Croisier F., Jérôme C. Chitosan-based biomaterials for tissue engineering. Eur. Polym. J. 2013;49:780–792. doi: 10.1016/j.eurpolymj.2012.12.009. [DOI] [Google Scholar]
  • 24.Mukherjee K., Ruan Q., Liberman D., White S.N., Moradian-Oldak J. Repairing human tooth enamel with leucine-rich amelogenin peptide-chitosan hydrogel. J. Mater. Res. 2016;31:556–563. doi: 10.1557/jmr.2016.64. [DOI] [Google Scholar]
  • 25.Elgadir M.A., Uddin M.S., Ferdosh S., Adam A., Chowdhury A.J.K., Sarker M.Z.I. Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review. J. Food Drug Anal. 2015;23:619–629. doi: 10.1016/j.jfda.2014.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Serra I.R., Fradique R., Vallejo M.C.S., Correia T.R., Miguel S.P., Correia I.J. Production and characterization of chitosan/gelatin/β-TCP scaffolds for improved bone tissue regeneration. Mater. Sci. Eng. C. 2015;55:592–604. doi: 10.1016/j.msec.2015.05.072. [DOI] [PubMed] [Google Scholar]
  • 27.Ikono R., Mardliyati E., Agustin I.T., Ulfi M.M.F., Andrianto D., Hasanah U., Bachtiar B.M., Mardianingsih N., Bachtiar E.W., Maulana N.N., Rochman N.T., Li X., Kagami H., Nagamura-Inoue T., Tojo A. Chitosan—PRP nanosphere as a growth factors slow releasing device with superior antibacterial capability. Biomed. Phys. Eng. Exp. 2019;4(4) doi: 10.1155/2013/878930. [DOI] [Google Scholar]
  • 28.Pina S., Oliveira J.M., Reis R.L. Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review. Adv. Mater. 2015;27:1143–1169. doi: 10.1002/adma.201403354. [DOI] [PubMed] [Google Scholar]
  • 29.Jiang T., Deng M., James R., Nair L.S., Laurencin C.T. Micro- and nanofabrication of chitosan structures for regenerative engineering. Acta Biomater. 2014;10:1632–1645. doi: 10.1016/j.actbio.2013.07.003. [DOI] [PubMed] [Google Scholar]
  • 30.Breuls R.G.M., Jiya T.U., Smit T.H. Scaffold stiffness influences cell behavior: opportunities for skeletal tissue engineering. Open Orthop. J. 2008;2:103–109. doi: 10.2174/1874325000802010103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kim B., Mooney D.J. Scaffolds for engineering smooth. Scanning. 2000;122:210–215. doi: 10.1115/1.429651. [DOI] [PubMed] [Google Scholar]
  • 32.Izquierdo R., Garcia-Giralt N., Rodriguez M.T., Cáceres E., García S.J. J.L. Gómez Ribelles, M. Monleón, J.C. Monllau, J. Suay, Biodegradable PCL scaffolds with an interconnected spherical pore network for tissue engineering. J. Biomed. Mater. Res. - Part A. 2008;85:25–35. doi: 10.1002/jbm.a.31396. [DOI] [PubMed] [Google Scholar]
  • 33.O’Brien F.J. Biomaterials & scaffolds for tissue engineering. Mater. Today. 2011;14:88–95. doi: 10.1016/S1369-7021(11)70058-X. [DOI] [Google Scholar]
  • 34.Vieth M., Siegel M.G., Higgs R.E., Watson I.A., Robertson D.H., Savin K.A., Durst G.L., Hipskind P.A. Characteristic physical properties and structural fragments of marketed oral drugs. J. Med. Chem. 2004;47:224–232. doi: 10.1021/jm030267j. [DOI] [PubMed] [Google Scholar]
  • 35.Schardosim M., Soulié J., Poquillon D., Cazalbou S., Duployer B., Tenailleau C., Rey C., Hübler R., Combes C. Freeze-casting for PLGA/carbonated apatite composite scaffolds: structure and properties. Mater. Sci. Eng. C. 2017;77:731–738. doi: 10.1016/j.msec.2017.03.302. [DOI] [PubMed] [Google Scholar]
  • 36.Taherkhani S., Moztarzadeh F. Fabrication of a poly(ε-caprolactone)/starch nanocomposite scaffold with a solvent-casting/salt-leaching technique for bone tissue engineering applications. J. Appl. Polym. Sci. 2016;133:19–21. doi: 10.1002/app.43523. [DOI] [Google Scholar]
  • 37.Yunus Basha R., Sampath S.K., Doble M. Design of biocomposite materials for bone tissue regeneration. Mater. Sci. Eng. C. 2015;57:452–463. doi: 10.1016/j.msec.2015.07.016. [DOI] [PubMed] [Google Scholar]
  • 38.Prasad A., Sankar M.R., Katiyar V. State of art on solvent casting particulate leaching method for orthopedic Scaffolds fabrication. Mater. Today Proc. 2017;4:898–907. doi: 10.1016/j.matpr.2017.01.101. [DOI] [Google Scholar]
  • 39.Kulkarni M., Mazare A., Gongadze E., Perutkova Š., Kralj-Iglic V., Milošev I., Schmuki P., Iglič A., Mozetič M. Titanium nanostructures for biomedical applications. Nanotechnology. 2015;26:1–18. doi: 10.1088/0957-4484/26/6/062002. [DOI] [PubMed] [Google Scholar]
  • 40.Cano L., Pollet E., Avérous L., Tercjak A. Effect of TiO2 nanoparticles on the properties of thermoplastic chitosan-based nano-biocomposites obtained by mechanical kneading. Compos. Part A Appl. Sci. Manuf. 2017;93:33–40. doi: 10.1016/j.compositesa.2016.11.012. [DOI] [Google Scholar]
  • 41.Chen X., Mao S.S. Titanium dioxide nanomaterials: synthesis, properties, modifications and applications. Chem. Rev. 2007;107:2891–2959. doi: 10.1021/cr0500535. [DOI] [PubMed] [Google Scholar]
  • 42.Mohammadi M., Hesaraki S., Hafezi-Ardakani M. Investigation of biocompatible nanosized materials for development of strong calcium phosphate bone cement: comparison of nano-titania, nano-silicon carbide and amorphous nano-silica. Ceram. Int. 2014;40:8377–8387. doi: 10.1016/j.ceramint.2014.01.044. [DOI] [Google Scholar]
  • 43.Brammer K.S., Frandsen C.J., Jin S. TiO2 nanotubes for bone regeneration. Trends Biotechnol. 2012;30:315–322. doi: 10.1016/j.tibtech.2012.02.005. [DOI] [PubMed] [Google Scholar]
  • 44.Nishiguchi S., Fujibayashi S., Kim H.-M., Kokubo T., Nakamura T. Surface potential change in bioactive titanium metal during the process of apatite formation in simulated body fluid. J. Biomed. Mater. Res. 2003;67A:1305–1309. doi: 10.1002/jbm.a.20039. [DOI] [PubMed] [Google Scholar]
  • 45.Kato H., Nakamura T., Nishiguchi S., Matsusue Y., Kobayashi M., Miyazaki T., Kim H.-M., Kokubo T. Bonding of alkali- and heat-treated tantalum implants to bone. J. Biomed. Mater. Res. Appl. Biomater. 2000;53:28–35. doi: 10.1002/(sici)1097-4636(2000)53:1<28::aid-jbm4>3.0.co;2-f. PMID: 10634949. [DOI] [PubMed] [Google Scholar]
  • 46.Tadashi K., Hiroaki T. Handbook of Biomineralization. 2007. Chapter 7: simulated body fluid (SBF) as a standard tool to test the bioactivity of implants; pp. 97–108. ISBN: 978-3-527-31806-3. [Google Scholar]
  • 47.Padovano J.D., Ramachandran A., Bahmanyar S., Ravindran S., George A. Bone-specific overexpression of DMP1 influences osteogenic gene expression during endochonral and intramembranous ossification. Connect. Tissue Res. 2014;55:121–124. doi: 10.3109/03008207.2014.923878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lu Y., Yuan B., Qin C., Cao Z., Xie Y., Dallas S.L., McKee M.D., Drezner M.K., Bonewald L.F., Feng J.Q. The biological function of DMP1 in Osteocyte Maturation is mediated by its 57-kDa C-terminal fragment. J. Bone Miner. Res. 2011;26:331–340. doi: 10.1002/jbmr.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wei J., Karsenty G. An overview of the metabolic functions of osteocalcin. Rev. Endocr. Metab. Disord. 2015;16:93–98. doi: 10.1007/s11154-014-9307-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Shen J., Hovhannisyan H., Lian J.B., Montecino M.A., Stein G.S., Stein J.L., Van Wijnen A.J. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones H3 and H4. Mol. Endocrinol. 2003;17:743–756. doi: 10.1210/me.2002-0122. [DOI] [PubMed] [Google Scholar]
  • 51.Wu S., Weng Z., Liu X., Yeung K.W.K., Chu P.K. Functionalized TiO2 based nanomaterials for biomedical applications. Adv. Funct. Mater. 2014;24 doi: 10.1002/adfm.201400706. [DOI] [Google Scholar]
  • 52.Syzmanska E., Winnicka K. Stability of chitosan—a challenge for pharmaceutical and biomedical applications. Mar. Drugs. 2015;13:1819–1846. doi: 10.3390/md13041819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Huang I.H., Hsiao C.T., Wu J.C., Shen R.F., Liu C.Y., Wang Y.K., Chen C.Y., Huang C.M., del Alamo J.C., Chang Z.F., Tang M.J., Khoo K.H., Kuo J.C. GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment. J. Cell. Sci. 2014;127:4186–4200. doi: 10.1242/jcs.150227. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biotechnology Reports are provided here courtesy of Elsevier

RESOURCES